Class of 2026
For unparalleled contributions to uncovering the molecular pathogenesis of esophageal adenocarcinoma and for pioneering minimally invasive cancer diagnostics through the development of the Cytosponge-TFF3, the first non-endoscopic test for Barrett’s esophagus, which has demonstrated over tenfold greater sensitivity in large-scale trials and transformed early detection by offering a practical, cost-effective alternative to endoscopy.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]